These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 582567)

  • 1. The central actions of nicotine on blood pressure and heart rate after administration via the left vertebral artery of anaesthetized cats. Distribution of nicotine into the brain after central application.
    Porsius AJ; Van Zwieten PA
    Arzneimittelforschung; 1978; 28(9):1628-31. PubMed ID: 582567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cardiovascular effects of physostigmine in the cat; possible cholinergic aspects of blood pressure regulation.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):22-39. PubMed ID: 6119963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central cardiovascular effects of a noncatecholamine endogenous ligand for clonidine receptors.
    Bousquet P; Feldman J; Atlas D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S167-71. PubMed ID: 2455173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine's central hypotensive effect: route of administration and localization in cat brain.
    McConnaughey MM; Ingenito AJ
    J Cardiovasc Pharmacol; 1982; 4(3):475-85. PubMed ID: 6177946
    [No Abstract]   [Full Text] [Related]  

  • 6. The release of vasopressin by nicotine: further studies on its site of action.
    Castro de Souza E; Rocha E Silva M
    J Physiol; 1977 Feb; 265(2):297-311. PubMed ID: 850196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachyphylaxis and sensitization to nicotine-induced tachycardiac and pressor effects after nicotine infusions.
    Cruz SL; Vidrio H
    Arch Med Res; 1997; 28(2):189-94. PubMed ID: 9204607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally induced cardiovascular effects and kinetic behaviour of isoarecaidine propyl ester in the cat.
    Porsius AJ; Lambrecht G; Moser U; Mutschler E
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):22-35. PubMed ID: 7092417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The simultaneous infusion of drugs via the left and right vertebral artery of the cat; a modified animal model for the study of possible central actions of drugs upon the lower brain stem.
    Porsius AJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):260-71. PubMed ID: 7224708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central action of various arecaidine esters (arecoline derivatives) on blood pressure and heart rate in the cat. Comparison with the peripheral effects.
    Porsius AJ; Mutschler E; Van Zwieten PA
    Arzneimittelforschung; 1978; 28(8):1373-6. PubMed ID: 582403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressor effects, drug concentration and cholinesterase activities in the brain after administration of paraoxon in the cat.
    De Neef JH; Van Rooy HH; Porsius AJ
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):15-27. PubMed ID: 6625764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central hypotensive activity of ketanserin in cats.
    van Zwieten PA; Mathy MJ; Boddeke HW; Doods HN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S54-8. PubMed ID: 2446072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of nicotinic and opioid processes in the medulla oblongata and nucleus ambiguus of the dog.
    Wu KM; Martin WR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):302-7. PubMed ID: 6313895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of nicotine, chlorisondamine, and mecamylamine in the pigeon.
    Chadman KK; Woods JH
    J Pharmacol Exp Ther; 2004 Jan; 308(1):73-8. PubMed ID: 14566012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine acts in the central nervous system to inhibit sympathetic neural activity.
    Raczkowski VF; Hernandez YM; Erzouki HK; Abrahams TP; Mandal AK; Hamosh P; Friedman E; Quest JA; Dretchen KL; Gillis RA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):511-9. PubMed ID: 2020007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ; Bucher T; Waite R
    J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally mediated hypotension and bradycardia induced by an aminotetralin derivative: TL-68.
    Sharabi FM; Long JP; Rusterholz DB; Hoffman WE; Lee T; Cannon GJ
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):457-73. PubMed ID: 674826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apnoeic responses to intracarotid nicotine challenge in anaesthetized cats.
    Szereda-Przestaszewska M; Kopczyńska B
    J Physiol Pharmacol; 2003 Jun; 54(2):151-62. PubMed ID: 12832718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system site of action of capsaicin-induced cardiovascular changes in the cat.
    Quest JA; Dias-Souza J; Norman WP; Holtman JR; Gillis RA
    J Pharmacol Exp Ther; 1984 Mar; 228(3):719-24. PubMed ID: 6707921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.